Krasteva, M E <br/><br/>
Breast cancer patients with hypermethylation in the promoter of BRCA1 gene exhibit favorable clinical status.  [electronic resource] 

 -  Neoplasma  2012 
 - 85-91 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0028-2685 
<br/><br/><label>Standard No.: </label>10.4149/neo_2012_011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Ataxia Telangiectasia Mutated Proteins<br/>Breast Neoplasms--genetics<br/>Bulgaria--epidemiology<br/>Carcinoma, Ductal, Breast--genetics<br/>Carcinoma, Lobular--genetics<br/>Cell Cycle Proteins--genetics<br/>Chi-Square Distribution<br/>Class I Phosphatidylinositol 3-Kinases<br/>DNA Methylation<br/>DNA-Binding Proteins--genetics<br/>Female<br/>Genes, BRCA1<br/>Genes, erbB-2<br/>Genes, p53<br/>Humans<br/>Kaplan-Meier Estimate<br/>Middle Aged<br/>Neoplasm Proteins--genetics<br/>Phosphatidylinositol 3-Kinases--genetics<br/>Promoter Regions, Genetic--genetics<br/>Proportional Hazards Models<br/>Protein Serine-Threonine Kinases--genetics<br/>Receptors, Estrogen--analysis<br/>Receptors, Progesterone--analysis<br/>Tumor Suppressor Proteins--genetics